Dr. Irving Weissman, head of Stanford University's Institute for Stem Cell Biology, answered your questions on stem cell research in California in light of the state's $3 billion bond on the issue - funds which have sparked a research "gold rush" among stem cell scientists.
My wife had a bad stroke two years ago. I found a U.S. company that will inject my wife with embryonic stem cells, but we would have to go outside the U.S. for the injection. Should we have the stem cells injected, or wait?
Dr. Irv Weissman responds:
You should be skeptical. Embryonic stem cells taken directly from the Petri dish can cause formation of cancers in the body. To date no one has yet converted these ES cells to transplantable useful cells for brain or any other tissue regeneration. These therapies, not cheap, are offshore because they haven't been taken through supervised and objective and controlled clinical trials. Nearly every country has its own FDA to make sure the treatments are done after adequate clinical trial testing. Make sure the company that proposes the treatment give you such testing approvals from their government agency. I'd wait several years until stem cell scientists find out first in animals if stroke can be repaired by stem cells or their derivatives. Not now.